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Abstract
The nuclear receptors REV-ERBα and REV-ERBβ have been demonstrated to be core mem-
bers of the circadian clock and participate in the regulation of a diverse set of metabolic func-
tions. Due to their overlapping tissue expression patterns and gene expression profiles,
REV-ERBβ is thought to be redundant to REV-ERBα. Recent work has highlighted REV-
ERBα’s role in the regulation of skeletal muscle oxidative capacity and mitochondrial biogen-
esis. Considering the similarity between the REV-ERBs and the hypothesized overlap in
function, we sought to determine whether REV-ERBβ-deficiency presented with a similar
skeletal muscle phenotype as REV-ERBα-deficiency. Ectopic overexpression in C2C12 cells
demonstrated that REV-ERBβ drives mitochondrial biogenesis and the expression of genes
involved in fatty acid oxidation. Intriguingly, knock down of REV-ERBβ in C2C12 cultures
also resulted in mitochondrial biogenesis and increased expression of genes involved in fatty
acid β-oxidation. To determine whether these effects occurred in vivo, we examined REV-
ERBβ-deficient mice and observed a similar increase in expression of genes involved in mito-
chondrial biogenesis and fatty acid β-oxidation. Consistent with these results, REV-ERBβ-
deficient mice exhibited an altered metabolic phenotype compared to wild-type littermate
controls when measured by indirect calorimetry. This likely compensated for the increased
food consumption that occurred, possibly aiding in the maintenance of their weight over time.
Since feeding behaviors are a direct circadian output, this study suggests that REV-ERBβ
may have more subtle effects on circadian behaviors than originally identified. Furthermore,
these data implicate REV-ERBβ in the control of skeletal muscle metabolism and energy
expenditure and suggest that development of REV-ERBα versus REV-ERBβ selective
ligands may have therapeutic utility in the treatment of metabolic syndrome.
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Introduction
In order to maintain homeostasis and promote survival, the circadian clock coordinates and
maintains the 24-hour rhythmicity of various physiological processes, the most evident are the
sleep/wake and fasting/feeding cycles[1, 2]. Disruption of the clock has been associated with
an increased susceptibility and/or development of sleep and metabolic disorders[1, 2]. Proper
circadian function occurs in response to synchronous expression of the molecular machinery
of the circadian clock, composed of a central pacemaker in the suprachiasmatic nucleus (SCN)
residing in the hypothalamus. While the master clock is entrained by light, almost all cells in
the body harbor peripheral clocks that are entrained by both signals from the master clock and
environmental cues[3]. This molecular machinery is comprised of core clock proteins that
control each other’s expression and function in a transcriptional/translation feedback loop;
two transcriptional activators, BMAL1 and CLOCK, heterodimerize and drive the expression
of Cryptochrome (Cry1, 2) and Period (Per1-3) [4]. Once Cryptochrome and Period proteins
reach a critical threshold, PER:CRY complexes translocate to the nucleus to repress Bmal1:
Clock transactivation[4]. In addition to these core clock components, the nuclear receptors
(NR) RORs (α, β, and γ) and the REV-ERBs (α and β) compete to activate and repress, respec-
tively, the transcription of Bmal1 and Clock genes, completing an integral accessory loop
which helps maintain circadian rhythmicity[5–7].
The REV-ERBs also participate in the regulation of a diverse set of metabolic processes,
thus linking control of our daily rhythms with maintenance of metabolic homeostasis[8]. Both
REV-ERBs are ubiquitously expressed with very high expression patterns in the liver, adipose
tissue, skeletal muscle, and brain, with both NRs exhibiting circadian patterns of expression
[9–11]. The REV-ERBs are unique within the NR superfamily in that they lack the carboxy-ter-
minal tail of the ligand binding domain (LBD called activation function 2 (AF-2, helix 12),
which is required for coactivator recognition. As a result, both REV-ERBs are transcriptional
repressors, recruiting corepressors such as NCoR in a ligand-dependent fashion. Both
REV-ERBs bind to identical DNA response elements (termed RORE/RevREs) either as mono-
mers to an AGGTCA “half site” with a 5’ AT-rich extension, or as homodimers to a DR2 ele-
ment [direct repeat (DR) AGGTCA sequence with a 2 base pair spacer][12, 13]. The retinoic
acid receptor-related orphan receptors [RORs (α, β, and γ)] recognize the same DNA response
element and are often coexpressed in the same tissues as the REV-ERBs[14]. Due to the limited
availability of genetic models to explore REV-ERBβ’s function, significantly more is known
about REV-ERBα’s role in mammalian physiology. As a consequence, REV-ERBβ is consid-
ered functionally redundant to REV-ERBα and its role has, by default, been considered almost
identical to REV-ERBα’s.
Recent work has demonstrated that REV-ERBα is highly expressed in oxidative skeletal
muscle and plays an integral role in mitochondrial biogenesis and oxidative function[15]. Skel-
etal muscle accounts for ~40% of body mass, more than 85% of total insulin-stimulated glu-
cose uptake, and is one of the most metabolically demanding major mass peripheral tissues[16,
17]. Consequently, skeletal muscle has a significant role in insulin sensitivity and the develop-
ment of obesity. Due to REV-ERBα’s role in skeletal muscle, REV-ERBα-deficient mice display
changes in daily energy expenditure, pre-disposing them to diet induce obesity[18]. Work per-
formed by Ramakrishnan and colleagues also demonstrated that REV-ERBβ was highly
expressed in skeletal muscle, regulating genes involved in fatty acid and lipid absorption[17].
Importantly, data presented by Ramakrishnan and colleagues implicated REV-ERBβ in the
control of lipid and energy homeostasis in skeletal muscle[17].
Given the overt skeletal muscle phenotype observed in REV-ERBα-deficient mice, coupled
with their metabolic abnormalities and the general view held by some in the field that
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REV-ERBβ is functionally redundant to REV-ERBα, we sought to determine the extent of
functional redundancy of REV-ERBβ to REV-ERBα in skeletal muscle and metabolism[19,
20]. Loss of REV-ERBβ resulted in increased mitochondrial biogenesis and genes involved in
muscle metabolism both in vitro and in vivo. Characterization of REV-ERBβ-deficient mice
demonstrated a metabolic profile opposite to that of REV-ERBα-deficient animals, including
failure to gain weight despite increased food consumption during the day. This increased food
consumption correlated with increased utilization of carbohydrates for energy as well as
increased energy expenditure during the day. These data indicate that, at least in terms of mus-
cle, REV-ERBβ is not functionally redundant to REV-ERBα, instead playing a distinct role in
the regulation of skeletal muscle metabolism. Furthermore, these data suggest development of
dissociated REV-ERB modulators (REV-ERBα-specific versus REV-ERBβ-specific) may be
beneficial for the treatment of metabolic syndrome.
Materials and methods
Animals
The following mouse strains used were either purchased from the Jackson Laboratory and/or
were bred at the Scripps Research Institute–Florida (Scripps Florida). Male B6.Cg-Nr1d1tm1Ven/
LazJ, stock # 018447 (REV-ERBα-/-)[21]; Male and female REV-ERBβ KO mice were generated
as previously described[22]. Wild-type (WT) littermates were used as controls for both knock
out strains. This study was carried out in accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health. Animal care
and experimental protocols used in this study were approved by the Scripps Florida Institu-
tional Animal Care and Use Committee (Assurance number: D16-00726). Mice were housed in
groups of 3–5 in 12 h light/12 h dark cycles at 23˚C and fed standard chow (Harlan 2920X),
unless otherwise stated. Mice had access to chow and water ad libitum. Mice were sacrificed by
CO2 asphyxiation for tissue processing.
Food intake
Food intake was monitored in normal chow-fed mice using the BioDAQ system (Research
Diets) following vendor recommended procedures. The feeding patterns of pre-acclimatized,
individually housed mice were continuously recorded for 3 consecutive days. The daily number
of bouts, percent of time spent in bouts and total chow consumed were obtained. A bout consti-
tutes a visit or set of visits (no more than 5 seconds apart) to the food hoppers. Each bout has a
duration and amount of food obtained during it. Data represent the average day or night intake.
Average values are compared by 2-tailed Student’s t test to determine significance.
CLAMS
Mice were individually placed and acclimatized in a Comprehensive Laboratory Monitoring
System (CLAMS; Columbus Instruments) at 23˚C for 48 h. Afterwards, VO2, VCO2, food
intake, and spontaneous locomotor activity were measured for the indicated time periods.
Respiratory exchange ratio (RER) and energy expenditure (EE) were calculated using the fol-
lowing equations: RER = VCO2/VO2; EE (kcal/h) = (3.815 + 1.232 X RER) x VO2. EE was nor-
malized by lean body mass. Both raw and average values for RER are presented.
Body composition studies
Total, fat, lean, and fluid mass of mice was measured by Nuclear Magnetic Resonance using
the Minispec LF-NMR (Brucker Optics) analyzer.
REV-ERB beta regulation of skeletal muscle
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Viral production, cell culture, and infection
To generate murine REV-ERBα or REV-ERBβ retroviral vectors, mouse REV-ERB sequences
were inserted into the MIGR1 vector (Addgene) using the XhoI site and further screened for
orientation. MIGR1 empty vector was used as a control. MIGR1 was a gift from Warren Pear
(Addgene, plasmid # 27490)[23]. To knock down REV-ERBβ expression, 3 different shRNA-
mirs (TransOmic Technologies, Inc.) were inserted, individually into the pLMPd-Ametrine
vector[24]. The shRNAmirs used were top-scoring designs from shERWOOD analysis
(TransOmic Technologies, Inc.). Each shRNAmir insert was PCR amplified using primers spe-
cific for common regions in the flanking miR-30 sequences, which included XhoI and EcoRI
sites. pLMPd-Ametrine containing a CD8 shRNA was used as a control.
Plat-E cells (Cell Biolabs, Inc.) were cultured in DMEM containing 10% fetal bovine serum,
2mM L-glutamine, and 1% penicillin/streptomycin at 37˚C under standard culture conditions.
Plat-E cells were seeded at 350,000 cells per mL in a 10cm dish the day before transfection. 5μg
total plasmid DNA was transfected via Fugene6 reagent (Promega) according to manufactur-
er’s protocol. Viral supernatant was harvested 48 and 72 hours post transfection and stored at
-80.
C2C12 myoblasts were obtained from ATCC (Manassas, VA) and grown in Dulbecco mod-
ified Eagle’s medium (DMEM; 4.5 g/l D-Glucose; Gibco) supplemented with 10% fetal bovine
serum, 2mM L-glutamine, and 1% penicillin (50units/mL)/streptomycin (50ug/mL). Prior to
myogenic differentiation, C2C12s were plated at 30,000 cells/mL in 24 well plates and left to
adhere overnight. The following day, cells were washed once with PBS and incubated over-
night in 1mL total of 50% retrovirus conditioned media and 50% normal culture media con-
taining Polybrene (8ug/mL, Santa Cruz Biotech). 24 hours later, retrovirus was removed and
replaced with normal growth media for another 24 hours before myogenic differentiation was
induced. One transduction was sufficient to obtain >90% GFP/Ametrine-positive cells. Myo-
genic differentiation into myotubes was induced after cells reached confluency by adding
DMEM supplemented with 2% horse serum (HS), 2mM L-glutamine, and 1% penicillin/strep-
tomycin at 37˚C in a humidified incubator under 5% CO2 for 6 days. Overexpression and
knock down was verified by qPCR analysis.
MitoTracker and flow cytometry
Retrovirally transduced C2C12 cells were washed with PBS, trypsinized and incubated at
37˚C for 20 min with 100nM MitoTracker RedFM dyes (Molecular Probes). MitoTracker
Red probe is a red-fluorescent dye that stains mitochondria in living cells and its accumula-
tion is dependent upon membrane potential (Molecular Probes). To measure viability in
the samples, a Fixable Viability Dye (Invitrogen/Thermo Fisher) was added to the cultures
during the Mitotracker staining step. This dye can be used to stain both live and fixed cells
to irreversibly label dead cells prior to analysis. Samples were washed three times in PBS
and flow cytometric analysis was performed on a BD LSRII (BD Biosciences) instrument
and analyzed using FlowJo software (TreeStar).
mtDNA quantification
Mitochondrial content was measured using methods previously described[25]. Briefly, geno-
mic DNA was extracted using the Blood & Cell culture DNA Mini Kit (Qiagen) per manufac-
turer’s instructions from C2C12 samples. DNA was quantified via a standard curve method in
order to dilute all samples to 3ng/ul in TE buffer. Once normalized for concentration, samples
were subject to RT-qPCR using a cocktail of SYBR green PCR master mix, template DNA, and
mtDNA target specific primer pairs, plus H2O. Each sample was run in triplicate and data
REV-ERB beta regulation of skeletal muscle
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were averaged. This step was repeated in separate wells using nuclear DNA specific primers
and the ratio between mtDNA and nuclear DNA was quantified. Dissociation curves were cal-
culated for all samples to ensure the presence of a single PCR product.
RNA isolation and quantitative real-time polymerase chain reaction
(qRT-PCR)
Muscle was harvested from WT and REV-ERBβ KO mice after a 5 hour fast, at ZT6 (Zeitgeber
6–6 hours into the murine nocturnal period). Total RNA was isolated from tissues by guanidi-
nium thiocyanate/phenol/chloroform extraction[15]. RNA concentrations were adjusted in
order to load 500ng of RNA per cDNA reaction. Total RNA was isolated from C2C12 cells
using a Quick-RNA MicroPrep kit (Zymo Research) using the manufacturers protocol. RNA
concentrations were adjusted in order to load 1μg of RNA per cDNA reaction. cDNA was syn-
thesized using qScriptTM cDNA SuperMix synthesis kit (Quanta Biosciences). Quantification
of each transcript by quantitative real time-polymerase chain reaction (qRT-PCR) was per-
formed using SYBR Green dye (Quanta Biosciences) to detect dsDNA synthesis, and analyzed
using cycling threshold (Ct) values. Relative expression was determined using the ΔΔCT
method and normalized to the housekeeping gene 18s. Quantitative RT-PCR was performed
with a 7900HT Fast Real Time PCR System (Applied Biosystems) using SYBR Green (Roche)
as previously described. Primers were designed using Primer3 (primer3.sourceforge.net).
Specificity and validation of the primers were determined using an In silico PCR software pro-
gram (genome.ucsd.edu) and melting curve analysis to eliminate the possibility of primer-
dimer artifacts and check reaction specificity. Primer sequences can be found in Table 1.
Statistical analysis
All data are expressed as mean±S.E.M. Statistical analysis was performed using GraphPad
Prism6 software. For multiple comparisons, two-way ANOVA was performed. Post-test analy-
sis (ANOVA) was performed correcting for multiple comparisons using the Sidak-Bonferroni
method. For all other independent data sets, since the data analyzed were not random, statisti-
cal significance was determined using two-tailed unpaired Student’s t-tests with no correction
for multiple comparisons[26]. ANCOVA analysis was performed using SPSS Statistics (IBM).
(N per group per study is indicated in each figure legend). Significance was assessed as follows:
p<0.05,  p<0.01,  p<0.005,  p<0.001.
Results
Overexpression of the REV-ERBs drives mitochondrial biogenesis
We previously demonstrated that REV-ERBα was a critical regulator of muscle mitochondrial
biogenesis[15]. To determine the cell autonomous role of REV-ERBβ versus REV-ERBα, we
utilized the C2C12 cell line, a well-studied cell culture model commonly used to investigate
myogenesis[27–30]. We retrovirally overexpressed REV-ERBα, REV-ERBβ, or empty vector
retrovirus in proliferating C2C12 myoblasts two days prior to the induction of differentiation
(Fig 1A). MitoTracker Red staining, indicative of functional mitochondria, revealed that over-
expression of both REV-ERBs enhanced mitochondrial biogenesis, demonstrated by increased
fluorescence in the REV-ERB overexpressing cells relative to empty vector control. Compared
to undifferentiated cells (Day 0; D0), the cells had differentiated and acquired a muscle specific
phenotype by Day 6 (D6). Very little difference was observed in expression of Myogenin
(Myog), Troponin I slow (Tnni1) and Troponin 1 fast (Tnni2), at Day 6 (D6) between groups
[17] (Fig 1B). No overt viability issues were observed by day 6. (S1A and S1B Fig)
REV-ERB beta regulation of skeletal muscle
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Overexpression of both REV-ERBs also resulted in increased mitochondrial content, indicated
by the increased expression of mitochondrial NADH dehydrogenase I (mt-Nd1), Cytochrome
c oxidase I (mt-Co1,) and Cytochrome c oxidase II (mt-Co2), compared to empty vector con-
trol cells (Fig 1C). These data suggest that the REV-ERBs can drive mitochondrial biogenesis
in vitro.
Overexpression of the REV-ERBs regulates the molecular clock and
mitochondrial metabolism genes
The REV-ERBs have been demonstrated to be core members of the circadian clock and partic-
ipate in the regulation of a diverse set of metabolic processes, thus linking control of our daily
rhythms with maintenance of metabolic homeostasis[8]. Given the changes in mitochondrial
content observed in the REV-ERB overexpressing cells, we next wanted to determine how
Table 1. List of qRT-PCR primers used in the study.
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expression of the clock genes correlated with expression of genes involved in mitochondrial
function. Overexpression of REV-ERBα (gene name Nr1d1) significantly repressed almost all
molecular clock genes, including REV-ERBβ (Nr1d2), Bmal1 (Arntl), Clock, the Crypto-
chromes (Cry1, Cry2), and the Period genes (Per1, Per2, Per3), which is consistent with its role
as a transcriptional repressor (Fig 2A). Overexpression of REV-ERBα also repressed expres-
sion of Cd36, a gene which is involved in lipid uptake[31]. In contrast, RORα and PGC1α
(Ppargc1a), the master regulator of mitochondrial biogenesis were upregulated with
REV-ERBα overexpression. Additionally, genes encoding enzymes of fatty acid β-oxidation,
notably carnitine palmitoyltransferase 1b (Cpt1b), long chain acyl-CoA dehydrogenase
(Acadl), short chain acyl-CoA dehydrogenase (Acads), Ucp2, and Ucp3, genes involved in skel-
etal muscle metabolism, were also upregulated with REV-ERBα overexpression, consistent
with previously published work (Fig 2A)[15, 32]. REV-ERBα also repressed expression of Ste-
rol regulatory element binding-protein 1 (Srebf1), Stearoyl-CoA desaturase-1 (Scd1), Fatty acid
synthase (Fasn), genes involved in lipogenesis, and Il6, a pleiotropic muscle myokine that has
been shown to be involved in muscle growth, myogenesis, and regulation of energy metabo-
lism (S1C Fig) [33]. Overexpression of REV-ERBβ had similar effects on circadian clock and
mitochondrial metabolism genes, with the exception that it potently repressed REV-ERBα
expression (Fig 2B). The negative regulation of REV-ERBα on REV-ERBβ expression and
vice-versa is consistent their ability to negatively regulate their own expression through con-
served ROREs/RevREs in their promoter regions[34, 35]. Interestingly, and in contrast to
Fig 1. The REV-ERBs modulate mitochondrial content in vitro. (A) Mitochondrial biogenesis determined by flow cytometry (FACS) using MitoTracker Red staining
in empty vector, REV-ERBα, and REV-ERBβ overexpressing C2C12s. FACS panels (left) indicate percent of cells retrovirally transduced. FACS panels (middle)
demonstrate overexpression of the REV-ERBs enhances MitoTracker Red staining. Graph (right) depicts median fluorescent intensity (MFI). (n = 3 per condition) (B)
qRT-PCR analysis of genes demonstrating cells had terminally differentiated. (C) Mitochondrial DNA (mtDNA) content demonstrated by the ratio of mtDNA to
nuclear DNA (nucDNA) in empty vector, REV-ERBα, and REV-ERBβ overexpressing C2C12s. nucDNA was measured using ß-actin (Actb) primers. (n = 3 per
condition) Values are mean±s.e.m. Data are representative of 4 independent experiments (Panels A & B) or 2 independent experiments (Panel C) demonstrating similar
results. Statistical significance was assessed using Student’s two-tailed t-tests. p<0.05,  p<0.01, p<0.001.
https://doi.org/10.1371/journal.pone.0196787.g001
REV-ERB beta regulation of skeletal muscle
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REV-ERBα overexpression, REV-ERBβ overexpression led to increased expression of Srebf1
and Fasn, but had no effects on expression of Scd1 or Il6 (S1C Fig). While it appears that
REV-ERBβ was not as effective as REV-ERBα in the overexpression studies, this could be due
to the differences in overexpression levels between the two receptors, with REV-ERBα being
more highly expressed than REV-ERBβ. Regardless, the increased expression of genes involved
in mitochondrial metabolism was consistent with the MitoTracker staining, mitochondrial
content, and skeletal muscle metabolism genes. These results demonstrate an inverse relation-
ship between the expression of the core circadian clock genes and the REV-ERBs and indicate
that overexpression of REV-ERBα and REV-ERBβ can modulate the expression of genes driv-
ing fatty acid β-oxidation and lipid metabolism in C2C12 cells. However, under some circum-
stances, REV-ERBβ can not completely fulfill REV-ERBα’s role.
Knock down of REV-ERBβ drives mitochondrial biogenesis
Work previously performed assessing REV-ERBβ’s function in C2C12s suggested that it plays
a significant role in the regulation of skeletal muscle lipid homeostasis. However, this analysis
Fig 2. The REV-ERBs modulate circadian and mitochondrial metabolic gene expression in vitro. (A) qRT-PCR analysis demonstrating that overexpression of
REV-ERBα largely represses expression of the molecular clock genes while driving expression of genes involved in mitochondrial metabolism, fatty acid uptake, and
fatty acid ß-oxidation. (B) qRT-PCR analysis demonstrating that overexpression of REV-ERBβ represses expression of the molecular clock genes while driving
expression of genes involved in mitochondrial metabolism, fatty acid uptake, and fatty acid ß-oxidation. 18s was used as the internal control. Values are mean±s.e.m.
Data are representative of 4 independent experiments demonstrating similar results. Statistical significance was assessed using Student’s two-tailed t-tests. p<0.05, 
p<0.01.
https://doi.org/10.1371/journal.pone.0196787.g002
REV-ERB beta regulation of skeletal muscle
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was performed in C2C12 cells using a dominant negative form of REV-ERBβ that lacked the
ligand binding domain[17]. Using this approach, Ramakrishnan and colleagues reported that
dominant negative REV-ERBβ largely repressed genes involved in skeletal muscle energy
expenditure and lipid catabolism[17]. These results were in line with data demonstrating that
loss of REV-ERBα in skeletal muscle led to decreased mitochondrial content and function[15].
Given the overlap in function observed in our overexpression studies, we hypothesized that
loss of REV-ERBβ would yield similar results as loss of REV-ERBα. Therefore, to fully assess
how loss of REV-ERBβ affects myogenesis, we retrovirally overexpressed a REV-ERBβ shRNA
or a CD8 control shRNA in proliferating C2C12 myoblasts 2 days prior to the induction of dif-
ferentiation (Fig 3A). Strikingly, knock down of REV-ERBβ enhanced mitochondrial biogene-
sis, indicated by the increased staining with MitoTracker Red. Analysis of Myog, Tnni1, and
Tnni2 indicated that compared to undifferentiated cells (Day 0, D0), the cells had differenti-
ated and acquired a muscle specific phenotype by Day 6 (D6). No overt viability issues were
observed by day 6. (S2A and S2B Fig) Furthermore, loss of REV-ERBβ appeared to signifi-
cantly increase expression of Tnni2. (Fig 3B) Knock down of REV-ERBβ also increased mito-
chondrial content, indicated by the increased expression of mt-Nd1, mt-Co1, and mt-Co2,
compared to CD8 shRNA control cells. Interestingly, while knock down of REV-ERBβ led to
increased expression of REV-ERBα and RORα, it also de-repressed all of the core molecular
clock genes. Like overexpression of REV-ERBα, overexpression of RORα has also been shown
to regulate the expression of genes involved in skeletal muscle metabolism[36]. Knock down of
REV-ERBβ also resulted in increased expression of almost all genes analyzed that were
involved in lipid and skeletal muscle metabolism, including Cd36, Cpt1b, Acadl, Ucp2, and
Ucp3, genes involved in skeletal muscle, which was consistent with the MitoTracker staining.
No change was observed in Acads. However, knock down of REV-ERBβ resulted in decreased
expression of PGC1α (Ppargc1a), Srebf1, Fasn, and Il6, but no change was observed in Scd1
(Fig 3D and S2C Fig). While these results were largely in contrast to previously published
work using a dominant negative REV-ERBβ construct, these results were at least consistent
with the notion that in C2C12 cells, REV-ERBβ plays a role in the regulation of muscle metab-
olism and energy expenditure. Interestingly, these data are in contrast to the overexpression
data and show a correlation between the circadian clock and skeletal muscle metabolic gene
expression.
Loss of REV-ERBβ drives skeletal muscle mitochondrial gene expression in
vivo
Given the surprising results we observed in C2C12 cells, we next wanted to determine
whether loss of REV-ERBβ affected skeletal muscle gene expression in vivo in a similar man-
ner. Using REV-ERBβ-deficient mice[22], we isolated (whole quadriceps) skeletal muscle
from wild-type (WT) and REV-ERBβ knock out (KO) mice at Zeitgeber 6 (ZT6), 6 hours
post lights-on and the time point in which peak REV-ERB mRNA expression occurs[37].
qRT-PCR analysis indicated that, similar to the C2C12 data, loss of REV-ERBβ de-repressed
most of the core clock genes, including REV-ERBα, RORα, Bmal1, and Clock. We observed
no effects on Cry2 or Per3 (Fig 4A). Similar results were observed in REV-ERBα KO muscle.
(Fig 4B) Loss of REV-ERBβ also led to increased expression of genes involved in lipid and
skeletal muscle metabolism (Cd36, Cpt1b, Acadl, Acads) and energy expenditure (Ucp2,
Ucp3) (Fig 4A). However, unlike the C2C12 cells, REV-ERBβ KO mice also had increased
expression of PGC1α (Ppargc1a). Similar to the C2C12s, REV-ERBβ KO mice also exhibited
decreased expression of Srebf1, Fasn, and Il6, with little effect observed on Scd1. (S3A Fig)
Moreover, loss of REV-ERBβ appeared to shift the muscle towards a more oxidative
REV-ERB beta regulation of skeletal muscle
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phenotype as we observed increased expression of tropomyosin 3 (Tpm3), a marker of oxi-
dative type 1 fiber and myosin heavy chain IIa (Myh2), a myosin heavy chain gene more
associated with oxidative fibers than others. The expression of Myh4, a marker of type 2b
glycolytic fibers, was unaltered (Fig 4A). The shift towards a more oxidative phenotype in
REV-ERBβ KO mice was in stark contrast to what was observed in REV-ERBα KO mice,
which was largely a shift towards a less oxidative phenotype demonstrated by decreased
expression of PGC1α, Cpt1b, Acadl, Acads, Ucp2, Ucp3, Myh2, and Tpm3 and is consistent
with previously published results[15]. (Fig 4B) However, not all changes in gene expression
between REV-ERBβ KO and REV-ERBα KO mice were conflicting. REV-ERBα KO mice
also demonstrated decreased expression of the lipogenic genes Srebf1 and Scd1 in muscle
Fig 3. REV-ERBβ knock down drives mitochondrial gene expression in vitro. (A) Mitochondrial biogenesis determined by flow cytometry (FACS) using MitoTracker
Red staining in empty vector and REV-ERBβ shRNA overexpressing C2C12s. FACS panels (left) indicate percent of cells retrovirally transduced. FACS panels (middle)
demonstrate knock down of REV-ERBβ enhances MitoTracker Red staining. Graph (right) depicts median fluorescent intensity (MFI). (B) qRT-PCR analysis of genes
demonstrating cells had terminally differentiated. (C) Mitochondrial DNA (mtDNA) content demonstrated by the ratio of mtDNA to nuclear DNA (nucDNA) in CD8
shRNA versus REV-ERBβ shRNA overexpressing C2C12s. nucDNA was measured using ß-actin (Actb) primers. (D) qRT-PCR analysis demonstrating the knock down
of REV-ERBβ and its effects on RORα, REV-ERBα, and genes encoding proteins involved in fatty acid oxidation and cytokine production. 18s was used as the internal
control. (n = 3 per condition). Values are mean±s.e.m. Data representative of 4 independent (Panels A, B, D) or two independent (Panel C) experiments demonstrating
similar results. Statistical significance was assessed using Student’s two-tailed t-tests. p<0.05,  p<0.01,  p<0.005,  p<0.001.
https://doi.org/10.1371/journal.pone.0196787.g003
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while loss of REV-ERBα de-repressed Fasn and Il6 (S3B Fig) However, unlike the muscle
tissue, gene expression analysis of livers from REV-ERBβ KO and REV-ERBα KO mice
demonstrated similar trends in gene expression (G6Pase, Cd36, Clock) or no effects (Pepck)
on gene expression in vivo (S3C and S3D Fig). These data are consistent with previously
published work indicating that REV-ERBα and REV-ERBβ have largely overlapping roles in
liver metabolism, with REV-ERBα acting as the dominant factor[19, 20]. These data suggest
that in liver, REV-ERBβ appears to have overlapping functions to REV-ERBα. However, in
skeletal muscle, the effects mediated by the loss of REV-ERBβ are in contrast to those of
REV-ERBα.
Fig 4. REV-ERBβ-deficient mice show increased muscle expression of mitochondrial and fatty acid oxidation genes compared to REV-ERBα-deficient mice. (A)
qRT-PCR analysis of muscle (quadriceps) from REV-ERBβ-deficient or wild-type littermate controls. Analysis includes effects on expression on RORα, REV-ERBα, and
core molecular clock genes as well as genes encoding proteins involved in fatty acid oxidation, lipid metabolism, and effects on expression on muscle fiber type (Tpm3,
Myh2, Myh4). (n = 7 mice per group) Data representative of 3 independent experiments demonstrating similar results. (B) qRT-PCR analysis of muscle (quadriceps)
from REV-ERBα-deficient or wild-type littermate controls. Analysis includes effects on expression on RORα, REV-ERBα, and core molecular clock genes as well as on
expression of genes encoding proteins involved in fatty acid oxidation, lipid metabolism, and expression on muscle fiber type (Tpm3, Myh2, Myh4). (n = 5 mice per
group) Data representative of 2 independent experiments demonstrating similar results. Values are mean±s.e.m. Statistical significance was assessed using Student’s
two-tailed t-tests. p<0.05,  p<0.01.
https://doi.org/10.1371/journal.pone.0196787.g004
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REV-ERBβ-deficient mice exhibit an altered circadian metabolism and
feeding schedule
Due to the increased expression of genes involved in mitochondrial biogenesis in the REV-
ERBβ KO mice compared to WT controls, we wanted to determine whether this translated to
effects on metabolism and any other circadian driven behavior. Real-time oxygen consump-
tion (VO2), carbon dioxide production (VCO2), ambulatory activity and food consumption
were monitored in twelve week-old male mice fed a normal chow diet using the CLAMS sys-
tem. Energy expenditure (EE) and RER (Respiratory exchange ratio) were calculated based on
the gas exchange as described in the Methods section (Fig 5A–5C). Body composition was
Fig 5. REV-ERBβ-deficient mice exhibit an altered metabolic phenotype and feeding schedule. (A) Real-time respiratory exchange ratio (RER) monitoring of pre-
acclimated male WT (black square) versus REV-ERBβ KO mice (gray circles) using indirect calorimetry. Mice were fed normal chow over a 3 day period. (F(380,4568) =
5.475, p<0.0001). (B) Average RER value, (C) energy expenditure, and (D) infrared activity beam break counts, indicating movement, for day versus night of the mice
in panel A. (n = 7 per group). (E) Food intake measurements of male WT (black square) versus male REV-ERBβ KO mice (gray circles) fed normal chow over a 2 day
period. (F) Average fasting RER value taken from a 6 hour period during the fast. (n = 7 per group) Data are representative of 2 independent experiments demonstrating
similar results. Experiments using female mice demonstrated similar results (data not shown). Values are mean±s.e.m. Average RER was obtained using ANCOVA
(analysis of covariance)[38] with ambulatory activity used as a covariate. Statistical significance was assessed using two-way ANOVA or Student’s two-tailed t-tests. 
p<0.05,  p<0.01,  p<0.005.
https://doi.org/10.1371/journal.pone.0196787.g005
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obtained just prior to the CLAMS analysis, with no differences observed in lean, fat, and fluid
masses or total body weight between groups (S4A Fig). The RER is a surrogate indicator of the
caloric source being utilized for energy production by an animal. It varies between 0.7, where
lipids are the predominant fuel source, to 1.0, where carbohydrates are the main contributors.
The REV-ERBβ KO mice showed a delay in the typical circadian drop in RER that occurs from
the dark to light phase transition when mice shift from high activity and feeding to resting
and sleep (Fig 5A and 5B). This prolonged high RER cycle indicates an increased relative con-
tribution of carbohydrates as an energy source in the KO animals. This could be due to their
increased chow consumption, observed during the light phase while in the CLAMS (S4B Fig).
This light-phase specific increase in eating was further confirmed in REV-ERBβ KO mice
tested in the BioDAQ system, which uses highly sensitive feeding monitoring hoppers adapted
to regular housing cages (Fig 5E, S4D Fig). Additionally, an increase in energy expenditure
was detected in association with the observed increased daytime chow consumption in the
REV-ERBβ KO mice (Fig 5C). Nighttime energy expenditure in REV-ERBβ KO mice was
comparable to WT mice, despite the KO animals being less active during this time (Fig 5D).
Whether the increase in energy expenditure in the KO mice during the daytime can be attrib-
uted to elevated feeding and digestive processes per se remains to be tested. Ambulatory activ-
ity during the light-phase was similar between the groups and thus, cannot explain that.
However, upon fasting, the KO’s demonstrated decreased RER relative to WT controls, which
may be a result from a faster transition to fat burning (Fig 5F). Regardless, the increased caloric
output can, at least in part, account for the absence of weight gain by the KO’s in spite of their
higher caloric intake (S4E Fig). These data indicate that REV-ERBβ regulates circadian behav-
iors and metabolism in vivo.
Discussion
REV-ERBα has recently been identified as a key regulator of skeletal muscle mitochondrial
function[15]. Due to the overlapping gene expression profiles and similarity in DNA binding
domains, REV-ERBβ is thought to be redundant to REV-ERBα. Our studies were aimed at
gaining a better understanding of REV-ERBβ’s function in skeletal muscle and overall metabo-
lism. In this report, we utilized the C2C12 in vitro cell culture model and REV-ERBβ-deficient
mice to investigate the role of this NR in comparison to REV-ERBα’s function in skeletal mus-
cle in vitro and in vivo. Here we report that overexpression and knock down of REV-ERBβ
drives mitochondrial biogenesis in C2C12 cells, exhibited by increased MitoTracker Red stain-
ing and increased expression of genes involved in skeletal muscle energy metabolism. We also
showed that skeletal muscle from REV-ERBβ KO mice exhibited a similar gene expression
profile as the C2C12 cells in which REV-ERBβ was knocked down, which was in contrast to
skeletal muscle gene expression in REV-ERBα KO mice. Furthermore, we demonstrated that
REV-ERBβ KO mice present with an altered metabolic phenotype and feeding behavior sched-
ule, with KO mice eating more and utilizing more carbohydrates as fuel during their noctur-
nal/sleep period. In terms of muscle and energy expenditure, our data suggest that REV-ERBβ
may not be as functionally redundant to REV-ERBα as originally hypothesized.
Our initial hypothesis was based on the view, held by some in the field, that REV-ERBα and
REV-ERBβ are functionally redundant, with REV-ERBα acting as the dominant factor[20].
Overexpression studies are excellent tools to determine whether a protein, in this case
REV-ERBβ, is able to perform certain cellular functions. Our initial studies in C2C12 cells sup-
ported this hypothesis as overexpression of each REV-ERB resulted in relatively similar func-
tional outputs, largely increased mitochondrial biogenesis and expression of genes involved in
skeletal muscle metabolism. However, the shRNA knock down of REV-ERBβ drove further
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inquiry into REV-ERBβ’s function in skeletal muscle. The increased MitoTracker Red staining
and the changes in gene expression observed surprised us, particularly since evaluation of
C2C12 cells using a dominant negative REV-ERBβ yielded opposite results to ours[17]. How-
ever, this construct still possessed REV-ERBβ’s N-terminal region, which has been shown to
interact with the transcriptional co-factor Tip60 in order to regulate gene transcription in a
ligand-independent manner[39, 40]. Thus, REV-ERBβ was not completely eliminated and
could have recruited co-factors to modify gene transcription in a ligand-independent manner.
Alternatively, since RORα and REV-ERBα bind the same DNA consensus sequence as
REV-ERBβ, the overexpression of the dominant negative REV-ERBβ could have blocked the
ability of RORα or REV-ERBα to bind to the RORE and again, affect transcription. However,
use of REV-ERBβ shRNA bypassed these issues and may account for the differences.
Overexpression of REV-ERBα has been demonstrated to drive mitochondrial biogenesis
whereas loss of REV-ERBα has the opposite effect[15]. However, the effects rendered by
overexpression and loss of REV-ERBβ were not opposite to each other. It is possible that the
increased mitochondrial biogenesis in the absence of REV-ERBβ is a consequence of increased
REV-ERBα or increased RORα. Indeed, we consistently observed increased expression of both
NRs in the absence of REV-ERBβ. Like overexpression of REV-ERBα, overexpression of
RORα has also been shown to regulate the transcription of genes involved in lipid metabolism
and energy metabolism in skeletal muscle[36]. REV-ERBα, RORα, and REV-ERBβ have been
demonstrated to bind to conserved ROREs/RevREs in REV-ERBα’s promoter region[34, 35],
with RORα driving gene expression whereas the REV-ERBs repress REV-ERBα gene expres-
sion. This autoregulation is likely the reason for the dramatic downregulation of gene expres-
sion observed on REV-ERBβ when REV-ERBα was overexpressed and vice versa. It is possible
that knock down or loss of REV-ERBβ relieved repression on REV-ERBα, hence the increased
expression in vitro and in vivo. Another possibility is that the overexpression of RORα, which
can also bind ROREs, drove gene expression and thus, increased mitochondrial biogenesis.
Alternatively, loss of REV-ERBβ could have relieved repression on Bmal1, which is known
to activate RORα and REV-ERBα transcription through binding to their respective E-box
regions[41]. Increased Bmal1 may account for the increased expression of REV-ERBα and
RORα observed both in vitro and in vivo. Future studies need to be performed to determine
the mechanism and which NRs may be driving the increased mitochondrial function in both
REV-ERBβ-deficient C2C12 cells and in skeletal muscle in vivo.
The circadian clock influences a broad range of physiological processes, including fasting/
feeding cycles[2]. Initial analysis of REV-ERBα KO versus REV-ERBβ KO mice indicated that
while loss of REV-ERBα affected circadian output, loss of REV-ERBβ had minimal effect[19].
However, our data indicate that REV-ERBβ does affect circadian gene expression in a manner
similar to REV-ERBα. Overexpression and knock-out of REV-ERBβ generated a similar gene
expression profile as REV-ERBα overexpression and knock-out. However, our data indicate
that at least in vitro, the circadian clock is not as intimately linked to skeletal muscle metabo-
lism as initially thought. While overexpression and knock down had different effects on
expression of core clock components, the skeletal muscle metabolic genes were consistently
upregulated and appeared to depend more on the expression of RORα and the REV-ERBs.
While this could also be said for the in vivo data, we do know that what occurs in vivo is signifi-
cantly more complex and REV-ERBα KO mice present with altered circadian rhythms, which
could affect the muscle phenotype[7, 15]. Our data also indicate that REV-ERBβ affects circa-
dian outputs, indicated by increased food consumption during the day. This increased food
intake could account for the shift and increased RER and EE observed during the day when
measured by indirect calorimetry. However, research has revealed that disordered eating, or
eating when we are supposed to be sleeping, contributes to weight gain, metabolic syndrome,
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and obesity[42, 43]. Despite this, REV-ERBβ KO mice do not gain weight over time, instead
maintaining similar weight profiles as WT littermate controls. It is possible that the metabolic
demands of the skeletal muscle may compensate for the increased food intake. This may also
explain the decreased activity observed in the REV-ERBβ KO mice during their “active” peri-
ods. That is, moving less compensated for the increased metabolism with no change in food
intake. Alternatively, the food intake during the day may have disrupted their sleep schedule
and the decreased movement may be a function of sleep compensation. Clearly, further in-
depth analysis of these behaviors is needed to better understand the phenotype observed.
Conclusions
REV-ERBβ plays a role in skeletal muscle mitochondrial biogenesis both in vitro and in vivo. This
effect on mitochondrial gene expression in REV-ERBβ KO mice differs from that of REV-ERBα
KO mice as each receptor appears to have effects opposite to each other. Furthermore, these dif-
ferences translate to profound differences on metabolism in vivo. Our data suggest that REV-
ERBβ may not be as functionally redundant to REV-ERBα as originally hypothesized. Thus,
development of dissociated REV-ERB modulators (REV-ERBα-specific versus REV-ERBβ-spe-
cific) may be beneficial for the treatment of metabolic syndrome.
Supporting information
S1 Fig. Overexpression of the REV-ERBs does not affect C2C12 viability but exerts differ-
ential effects on genes involved in lipid metabolism. (A) Flow cytometry (FACS) after 6 days
in culture using a viability dye. FACS panels (top) are representative plots of the overall health
of the C2C12 cultures on Day 6. Graph (bottom) represents the average viability across all cul-
tures per condition (n = 3). (B) Representative images of the C2C12 cultures at 10x and 20x
magnification on Day 6 demonstrating the differentiation of the cells and no overt cell death.
(C) qRT-PCR analysis of genes involved in lipid metabolism and inflammation, including
Srebf1, Scd1, Fasn, and Il6 in C2C12 cells overexpressing REV-ERBa (top) or REV-ERBß (bot-
tom) relative to empty vector control. Data are representative of 3 separate experiments dem-
onstrating similar results. Statistical significance was assessed using Student’s two-tailed t-
tests. p<0.05.
(TIFF)
S2 Fig. Knock-down of REV-ERBβ does not affect C2C12 viability but inhibits expression
of genes involved in lipid metabolism. (A) Cell viability determined by flow cytometry
(FACS) after 6 days in culture using a viability dye. FACS panels (top) are representative plots
of the overall health of the C2C12 cultures on Day 6. Graph (bottom) represents the average
viability across all cultures per condition (n = 3). (B) Representative images of the C2C12 cul-
tures at 10x and 20x magnification on Day 6 demonstrating the differentiation of the cells and
no overt cell death. (C) qRT-PCR analysis of genes involved in lipid metabolism and inflam-
mation, including Srebf1, Scd1, Fasn, and Il6 in C2C12 cells in which REV-ERBβ was knocked
down relative to CD8 control. Data are representative of 3 separate experiments demonstrating
similar results. Statistical significance was assessed using Student’s two-tailed t-tests. p<0.05.
(TIFF)
S3 Fig. REV-ERBβ-deficient mice show differential expression of lipid metabolism genes
in muscle compared to REV-ERBα-deficient mice, but not liver. (A) qRT-PCR analysis of
muscle (quadriceps) from REV-ERBβ-deficient or wild-type littermate controls. Analysis
includes effects on expression of genes involved in lipid metabolism and inflammation, includ-
ing Srebf1, Scd1, Fasn, and Il6. (B) qRT-PCR analysis of muscle (quadriceps) from REV-ERBα-
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deficient or wild-type littermate controls. Analysis includes effects on expression of genes
involved in lipid metabolism, including Srebf1, Scd1, Fasn, and Il6. (C) qRT-PCR analysis of
genes involved in glucose metabolism (G6pase, Pepck), lipid uptake (Cd36), and circadian
function (Clock) from livers of REV-ERBβ-deficient or wild-type littermate controls. (n = 7
mice per group) Data representative of 3 independent experiments demonstrating similar
results. (D) qRT-PCR analysis of genes involved in glucose metabolism (G6pase, Pepck), lipid
uptake (Cd36), and circadian function (Clock) from livers of REV-ERBα-deficient or wild-type
littermate controls. For REV-ERBß KO mice: (n = 7 mice per group) Data representative of 3
independent experiments demonstrating similar results. For REV-ERBa KO mice: (n = 5 mice
per group) Data representative of 2 independent experiments demonstrating similar results.
Values are mean±s.e.m. Statistical significance was assessed using Student’s two-tailed t-tests.
p<0.05.
(TIFF)
S4 Fig. REV-ERBβ-deficient mice consume more food than WT littermate controls. (A)
Body weight and body composition of the mice in the metabolic chambers experiment. (B)
Measurement of accumulated food intake of chow-fed, male WT and REV-ERBβ KO mice
during their time in the metabolic chambers. (C) Analysis of food intake for 12-hour periods
(day versus night) in male WT and REV-ERBβ KO mice during their time in the metabolic
chambers. (D) Table indicating the average daily food intake, number of bouts, and % time in
each bout for WT and REV-ERBβ KO mice in the BioDAQ experiments. (E) Body weight and
body composition analysis of male mice from Fig 4 at 30 weeks of age. (n = 7 mice per group).
Similar results were observed in separate cohorts of male and female mice. Values are mean±s.
e.m. Statistical significance was assessed using Student’s two-tailed t-tests. p<0.05.
(TIFF)
Acknowledgments
We would like to thank Dr. Nelson Bruno for his helpful comments and critiques of experi-
mental design and data analysis.
Author Contributions
Conceptualization: Laura A. Solt.
Data curation: Melissa Kazantzis.
Formal analysis: Melissa Kazantzis, Laura A. Solt.
Funding acquisition: Thomas P. Burris, Laura A. Solt.
Investigation: Ariadna Amador, Sean Campbell, Melissa Kazantzis, Gary Lan.
Supervision: Laura A. Solt.
Writing – original draft: Laura A. Solt.
Writing – review & editing: Ariadna Amador, Melissa Kazantzis, Thomas P. Burris, Laura A.
Solt.
References
1. Marcheva B, Ramsey KM, Affinati A, Bass J. Clock genes and metabolic disease. J Appl Physiol
(1985). 2009; 107(5):1638–46. https://doi.org/10.1152/japplphysiol.00698.2009 PMID: 19661448;
PubMed Central PMCID: PMCPMC2777795.
REV-ERB beta regulation of skeletal muscle
PLOS ONE | https://doi.org/10.1371/journal.pone.0196787 May 3, 2018 16 / 19
2. Marcheva B, Ramsey KM, Peek CB, Affinati A, Maury E, Bass J. Circadian clocks and metabolism.
Handb Exp Pharmacol. 2013;(217):127–55. https://doi.org/10.1007/978-3-642-25950-0_6 PMID:
23604478; PubMed Central PMCID: PMCPMC4089089.
3. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordina-
tion of central and peripheral clocks. Annu Rev Physiol. 2010; 72:517–49. Epub 2010/02/13. https://doi.
org/10.1146/annurev-physiol-021909-135821 PMID: 20148687.
4. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and dis-
order: implications for physiology and disease. Nature reviews Genetics. 2008; 9(10):764–75. Epub
2008/09/20. https://doi.org/10.1038/nrg2430 PMID: 18802415; PubMed Central PMCID:
PMC3758473.
5. Crumbley C, Burris TP. Direct regulation of CLOCK expression by REV-ERB. PloS one. 2011; 6(3):
e17290. Epub 2011/04/12. https://doi.org/10.1371/journal.pone.0017290 PMID: 21479263; PubMed
Central PMCID: PMC3066191.
6. Crumbley C, Wang Y, Kojetin DJ, Burris TP. Characterization of the core mammalian clock component,
NPAS2, as a REV-ERBalpha/RORalpha target gene. The Journal of biological chemistry. 2010; 285
(46):35386–92. https://doi.org/10.1074/jbc.M110.129288 PMID: 20817722; PubMed Central PMCID:
PMCPMC2975162.
7. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, et al. The orphan nuclear
receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circa-
dian oscillator. Cell. 2002; 110(2):251–60. Epub 2002/08/02. doi: S0092867402008255 [pii]. PMID:
12150932.
8. Solt LA, Kojetin DJ, Burris TP. The REV-ERBs and RORs: molecular links between circadian rhythms
and lipid homeostasis. Future medicinal chemistry. 2011; 3(5):623–38. https://doi.org/10.4155/fmc.11.9
PMID: 21526899; PubMed Central PMCID: PMC3134326.
9. Dumas B, Harding HP, Choi HS, Lehmann KA, Chung M, Lazar MA, et al. A new orphan member of the
nuclear hormone receptor superfamily closely related to Rev-Erb. Molecular endocrinology. 1994; 8
(8):996–1005. https://doi.org/10.1210/mend.8.8.7997240 PMID: 7997240.
10. Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES, et al. Cross-talk among ROR
alpha 1 and the Rev-erb family of orphan nuclear receptors. Molecular endocrinology. 1994; 8(9):1253–
61. https://doi.org/10.1210/mend.8.9.7838158 PMID: 7838158.
11. Bonnelye E, Vanacker JM, Desbiens X, Begue A, Stehelin D, Laudet V. Rev-erb beta, a new member of
the nuclear receptor superfamily, is expressed in the nervous system during chicken development. Cell
growth & differentiation: the molecular biology journal of the American Association for Cancer
Research. 1994; 5(12):1357–65. PMID: 7696184.
12. Harding HP, Lazar MA. The orphan receptor Rev-ErbA alpha activates transcription via a novel
response element. Molecular and cellular biology. 1993; 13(5):3113–21. Epub 1993/05/01. PMID:
8474464; PubMed Central PMCID: PMC359704.
13. Harding HP, Lazar MA. The monomer-binding orphan receptor Rev-Erb represses transcription as a
dimer on a novel direct repeat. Molecular and cellular biology. 1995; 15(9):4791–802. Epub 1995/09/01.
PMID: 7651396; PubMed Central PMCID: PMC230723.
14. Smith AG, Muscat GE. Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. Ameri-
can journal of physiology Cell physiology. 2006; 291(2):C203–17. https://doi.org/10.1152/ajpcell.00476.
2005 PMID: 16825600.
15. Woldt E, Sebti Y, Solt LA, Duhem C, Lancel S, Eeckhoute J, et al. Rev-erb-alpha modulates skeletal
muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nature medicine.
2013; 19(8):1039–46. https://doi.org/10.1038/nm.3213 PMID: 23852339; PubMed Central PMCID:
PMC3737409.
16. Smith AG, Muscat GE. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular
and metabolic disease. The international journal of biochemistry & cell biology. 2005; 37(10):2047–63.
https://doi.org/10.1016/j.biocel.2005.03.002 PMID: 15922648.
17. Ramakrishnan SN, Lau P, Burke LJ, Muscat GE. Rev-erbbeta regulates the expression of genes
involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear
receptors and myokines. The Journal of biological chemistry. 2005; 280(10):8651–9. https://doi.org/10.
1074/jbc.M413949200 PMID: 15623503.
18. Delezie J, Dumont S, Dardente H, Oudart H, Grechez-Cassiau A, Klosen P, et al. The nuclear receptor
REV-ERBalpha is required for the daily balance of carbohydrate and lipid metabolism. FASEB journal:
official publication of the Federation of American Societies for Experimental Biology. 2012; 26(8):3321–
35. https://doi.org/10.1096/fj.12-208751 PMID: 22562834.
REV-ERB beta regulation of skeletal muscle
PLOS ONE | https://doi.org/10.1371/journal.pone.0196787 May 3, 2018 17 / 19
19. Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, et al. Regulation of circadian behaviour and
metabolism by REV-ERB-alpha and REV-ERB-beta. Nature. 2012; 485(7396):123–7. https://doi.org/
10.1038/nature11048 PMID: 22460952; PubMed Central PMCID: PMCPMC3367514.
20. Bugge A, Feng D, Everett LJ, Briggs ER, Mullican SE, Wang F, et al. Rev-erbalpha and Rev-erbbeta
coordinately protect the circadian clock and normal metabolic function. Genes Dev. 2012; 26(7):657–
67. https://doi.org/10.1101/gad.186858.112 PMID: 22474260; PubMed Central PMCID:
PMCPMC3323877.
21. Chomez P, Neveu I, Mansen A, Kiesler E, Larsson L, Vennstrom B, et al. Increased cell death and
delayed development in the cerebellum of mice lacking the rev-erbA(alpha) orphan receptor. Develop-
ment. 2000; 127(7):1489–98. PMID: 10704394.
22. Banerjee S, Wang Y, Solt LA, Griffett K, Kazantzis M, Amador A, et al. Pharmacological targeting of the
mammalian clock regulates sleep architecture and emotional behaviour. Nat Commun. 2014; 5:5759.
https://doi.org/10.1038/ncomms6759 PMID: 25536025; PubMed Central PMCID: PMCPMC4495958.
23. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, et al. Efficient and rapid induction of a
chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-trans-
duced bone marrow. Blood. 1998; 92(10):3780–92. Epub 1998/11/10. PMID: 9808572.
24. Chen R, Belanger S, Frederick MA, Li B, Johnston RJ, Xiao N, et al. In vivo RNA interference screens
identify regulators of antiviral CD4(+) and CD8(+) T cell differentiation. Immunity. 2014; 41(2):325–38.
https://doi.org/10.1016/j.immuni.2014.08.002 PMID: 25148027; PubMed Central PMCID:
PMCPMC4160313.
25. Rooney JP, Ryde IT, Sanders LH, Howlett EH, Colton MD, Germ KE, et al. PCR based determination of
mitochondrial DNA copy number in multiple species. Methods Mol Biol. 2015; 1241:23–38. Epub 2014/
10/14. https://doi.org/10.1007/978-1-4939-1875-1_3 PMID: 25308485; PubMed Central PMCID:
PMCPMC4312664.
26. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990; 1(1):43–6.
Epub 1990/01/01. PMID: 2081237.
27. Muscat GE, Wagner BL, Hou J, Tangirala RK, Bischoff ED, Rohde P, et al. Regulation of cholesterol
homeostasis and lipid metabolism in skeletal muscle by liver X receptors. The Journal of biological
chemistry. 2002; 277(43):40722–8. https://doi.org/10.1074/jbc.M206681200 PMID: 12193599.
28. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated
receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism
and energy uncoupling in skeletal muscle cells. Molecular endocrinology. 2003; 17(12):2477–93.
https://doi.org/10.1210/me.2003-0151 PMID: 14525954.
29. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA. Nutritional regulation and role of
peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochimica
et biophysica acta. 2003; 1633(1):43–50. PMID: 12842194.
30. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, et al. Peroxisome-proliferator-activated receptor
delta activates fat metabolism to prevent obesity. Cell. 2003; 113(2):159–70. PMID: 12705865.
31. Glatz JF, Luiken JJ. From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid
uptake. Biochimie. 2017; 136:21–6. Epub 2016/12/26. https://doi.org/10.1016/j.biochi.2016.12.007
PMID: 28013071.
32. Jornayvaz FR, Shulman GI. Regulation of mitochondrial biogenesis. Essays Biochem. 2010; 47:69–84.
https://doi.org/10.1042/bse0470069 PMID: 20533901; PubMed Central PMCID: PMCPMC3883043.
33. Munoz-Canoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal
muscle: a double-edged sword? FEBS J. 2013; 280(17):4131–48. https://doi.org/10.1111/febs.12338
PMID: 23663276; PubMed Central PMCID: PMCPMC4163639.
34. Adelmant G, Begue A, Stehelin D, Laudet V. A functional Rev-erb alpha responsive element located in
the human Rev-erb alpha promoter mediates a repressing activity. Proceedings of the National Acad-
emy of Sciences of the United States of America. 1996; 93(8):3553–8. PMID: 8622974; PubMed Cen-
tral PMCID: PMCPMC39648.
35. Raspe E, Mautino G, Duval C, Fontaine C, Duez H, Barbier O, et al. Transcriptional regulation of human
Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor
alpha. The Journal of biological chemistry. 2002; 277(51):49275–81. https://doi.org/10.1074/jbc.
M206215200 PMID: 12377782.
36. Lau P, Nixon SJ, Parton RG, Muscat GE. RORalpha regulates the expression of genes involved in lipid
homeostasis in skeletal muscle cells: caveolin-3 and CPT-1 are direct targets of ROR. The Journal of
biological chemistry. 2004; 279(35):36828–40. https://doi.org/10.1074/jbc.M404927200 PMID:
15199055.
REV-ERB beta regulation of skeletal muscle
PLOS ONE | https://doi.org/10.1371/journal.pone.0196787 May 3, 2018 18 / 19
37. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T, et al. Regulation of circadian behav-
iour and metabolism by synthetic REV-ERB agonists. Nature. 2012; 485(7396):62–8. https://doi.org/10.
1038/nature11030 PMID: 22460951; PubMed Central PMCID: PMC3343186.
38. Tschop MH, Speakman JR, Arch JR, Auwerx J, Bruning JC, Chan L, et al. A guide to analysis of mouse
energy metabolism. Nature methods. 2011; 9(1):57–63. https://doi.org/10.1038/nmeth.1806 PMID:
22205519; PubMed Central PMCID: PMC3654855.
39. Simons SS Jr., Edwards DP, Kumar R. Minireview: dynamic structures of nuclear hormone receptors:
new promises and challenges. Molecular endocrinology. 2014; 28(2):173–82. https://doi.org/10.1210/
me.2013-1334 PMID: 24284822; PubMed Central PMCID: PMCPMC3896641.
40. Wang J, Liu N, Liu Z, Li Y, Song C, Yuan H, et al. The orphan nuclear receptor Rev-erbbeta recruits
Tip60 and HDAC1 to regulate apolipoprotein CIII promoter. Biochimica et biophysica acta. 2008; 1783
(2):224–36. https://doi.org/10.1016/j.bbamcr.2007.09.004 PMID: 17996965.
41. De Mei C, Ercolani L, Parodi C, Veronesi M, Lo Vecchio C, Bottegoni G, et al. Dual inhibition of REV-
ERBbeta and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells.
Oncogene. 2015; 34(20):2597–608. Epub 2014/07/16. https://doi.org/10.1038/onc.2014.203 PMID:
25023698.
42. Stucchi P, Gil-Ortega M, Merino B, Guzman-Ruiz R, Cano V, Valladolid-Acebes I, et al. Circadian feed-
ing drive of metabolic activity in adipose tissue and not hyperphagia triggers overweight in mice: is there
a role of the pentose-phosphate pathway? Endocrinology. 2012; 153(2):690–9. https://doi.org/10.1210/
en.2011-1023 PMID: 22147018.
43. Arble DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to
weight gain. Obesity. 2009; 17(11):2100–2. https://doi.org/10.1038/oby.2009.264 PMID: 19730426;
PubMed Central PMCID: PMCPMC3499064.
REV-ERB beta regulation of skeletal muscle
PLOS ONE | https://doi.org/10.1371/journal.pone.0196787 May 3, 2018 19 / 19
